Johnson & Johnson launched the Virtuguide System, an AI-powered, patient-matched solution designed to support Lapidus procedures, a type of bunion surgery that helps realign the foot by joining two bones near the arch. The system uses pre-operative planning software, developed in collaboration with PeekMed, to assess each patient’s bunion and make personalized recommendations for the intended correction and reduce surgical complexity. This launch follows the 510(k) clearance from the FDA for the Pre-operative Planning Software, granted earlier this year.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
- How Johnson & Johnson Stock (JNJ) Discovered a New Lease on Life
- Pacira upgraded to Buy from Hold at Truist
- Johnson & Johnson management to meet with Oppenheimer
- Halozyme says EU approves new indication for Janssen’s Darzalex Faspro